Your selections:
Dynamin inhibition blocks botulinum neurotoxin type A endocytosis in neurons and delays botulism
- Harper, Callista B., Martin, Sally, Robinson, Phillip J., Meunier, Frederic A., Nguyen, Tam H., Daniels, Shari J., Lavidis, Nickolas A., Popoff, Michel R., Hadzic, Gordana, Mariana, Anna, Chau, Ngoc, McCluskey, Adam
Actin- and dynamin-dependent maturation of bulk endocytosis restores neurotransmission following synaptic depletion
- Nguyen, Tam H., Maucort, Guillaume, Sullivan, Robert K. P., Schenning, Mitja, Lavidis, Nickolas A., McCluskey, Adam, Robinson, Phillip J., Meunier, Frederic A.
Development of 1,8-naphthalimides as clathrin inhibitors
- MacGregor, Kylie A., Robertson, Mark J., Young, Kelly A., von Kleist, Lisa, Stahlschmidt, Wiebke, Whiting, Ainslie, Chau, Ngoc, Robinson, Phillip J., Haucke, Volker, McCluskey, Adam
Targeting membrane trafficking in infection prophylaxis: dynamin inhibitors
- Harper, Callista B., Popoff, Michel R., McCluskey, Adam, Robinson, Phillip J., Meunier, Frederic A.
- Baluska, Frantisek, Hlavacka, Andrej, Samaj, Jozef, Palme, Klaus, Robinson, David G., Matoh, Toru, McCurdy, David W., Menzel, Diedrik, Volkmann, Dieter
Disruption of clathrin-mediated endocytosis through small molecule inhibition of dynamin and clathrin
- Baluska, F., Liners, F., Hlavacka, A., Schlicht, M., Van Cutsem, P., McCurdy, D. W., Menzel, D.
5-Aryl-2-(naphtha-1-yl)sulfonamido-thiazol-4(5H)-ones as clathrin inhibitors
- Robertson, Mark J., Horatscheck, André, Haucke, Volker, McCluskey, Adam, Sauer, Samantha, von Kleist, Lisa, Baker, Jennifer R., Stahlschmidt, Wiebke, Nazaré, Marc, Whiting, Ainslie, Chau, Ngoc, Robinson, Phillip J.
Twenty-six novel EFNB1 mutations in familial and sporadic cranlofrontonasal syndrome (CFNS)
- Wieland, I., Reardon, W., Jakubiczka, S., Franco, B., Kress, W., Vincent-Delorme, C., Thierry, P., Edwards, Matthew, Konig, R., Rusu, C., Schweiger, S., Thompson, E., Tinschert, S., Stewart, F., Wieacker, P.
Small molecule inhibitors of dynamin I GTPase activity: development of dimeric tyrphostins
- Hill, Timothy, Odell, Luke, McCluskey, Adam, Edwards, Jennifer K., Graham, Mark E., McGeachie, Andrew B., Rusak, Jenny, Quan, Annie, Abagyan, Ruben, Scott, Janet L., Robinson, Phillip J.
Development of quinone analogues as dynamin GTPase inhibitors
- MacGregor, Kylie A., Abdel-Hamid, Mohammed K., Odell, Luke R., Chau, Ngoc, Whiting, Ainslie, Robinson, Phillip J., McCluskey, Adam
- Jensen, Dane D., Lieu, TinaMarie, Herenbrink, Carmen Klein, Barlow, Nicholas, Simpson, James S., Scanlon, Martin J., Graham, Bimbil, McCluskey, Adam, Robinson, Phillip J., Escriou, Virginie, Nassini, Romina, Materazzi, Serena, Halls, Michelle L., Geppetti, Pierangelo, Hicks, Gareth A., Christie, Macdonald J., Porter, Christopher J. H., Canals, Meritxell, Bunnett, Nigel W., Veldhuis, Nicholas A., Imlach, Wendy L., Mai, Quynh N., Poole, Daniel P., Quach, Tim, Aurelio, Luigi, Conner, Joshua
Shutting the gate: targeting endocytosis in acute leukemia
- Tremblay, Cedric S., Ting, Stephen B., McCluskey, Adam, Robinson, Phillip J., Curtis, David J.
Are you sure you would like to clear your session, including search history and login status?